SANDRA ROGERS: Open Payments
NPI 1811625882 · CLINTON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$621 in 33 payments from 15 companies in 2025. Trend: 2023 $150 · 2024 $249 · 2025 $621
Food & beverage: $621
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $101 |
| GlaxoSmithKline, LLC. | 6 | $89 |
| Otsuka America Pharmaceutical, Inc. | 4 | $82 |
| Novo Nordisk Inc | 3 | $59 |
| Exact Sciences Corporation | 3 | $51 |
| Lundbeck LLC | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Amgen Inc. | 2 | $31 |
| KYOWA KIRIN, INC. | 1 | $25 |
| SANOFI-AVENTIS U.S. LLC | 1 | $25 |
Products named: REXULTI, CAPLYTA, Cologuard Collection Kit, TRELEGY ELLIPTA, SHINGRIX, AIRSUPRA, CRYSVITA, TZIELD.
Industry payments across IN — which companies pay providers there.
